22 results

e51 Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database
Hyun-Woong Cho, Yung-Taek Ouh, Jin Hwa Hong, Jae Kwan Lee
KMSID: 1125140   J Gynecol Oncol. 2019;30(4):e51.  Published online 2019 July 4    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e51
         
e52 Human papillomavirus genotype-specific risk in cervical carcinogenesis
Kyeong A So, In Ho Lee, Ki Heon Lee, Sung Ran Hong, Young Jun Kim, Hyun Hee Seo, Tae Jin Kim
KMSID: 1125141   J Gynecol Oncol. 2019;30(4):e52.  Published online 2019 February 11    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e52
         
e53 Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
Pierre-Alain Reboux, Henri Azaïs, Charles-Henry Canova, Sofiane Bendifallah, Lobna Ouldamer, Emilie Raimond, Delphine Hudry, Charles Coutant, Olivier Graesslin, Cyril Touboul, Pierre Collinet, Alexandre Bricou, Cyrille Huchon, Emile Daraï, Marcos Ballester, Jean Lévêque, Vincent Lavoué, Martin Koskas, Catherine Uzan, Geoffroy Canlorbe
KMSID: 1125142   J Gynecol Oncol. 2019;30(4):e53.  Published online 2019 February 7    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e53
         
e54 Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes
Hanifi Şahin, Funda Karatas, Gonca Coban, Özlem Özen, Özlem Erdem, Mehmet Anıl Onan, Ali Ayhan
KMSID: 1125143   J Gynecol Oncol. 2019;30(4):e54.  Published online 2019 July 4    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e54
         
e55 Stage and histology of cervical cancer in women under 25 years old
Diama Bhadra Vale, Lucas Almeida Cavalcante, Liliana Aparecida Lucci De Angelo Andrade, Julio Cesar Teixeira, Talita Lourenço do Rio Menin, Luiz Carlos Zeferino
KMSID: 1125144   J Gynecol Oncol. 2019;30(4):e55.  Published online 2019 February 26    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e55
         
e56 Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer
Marius C. Normann, Martin Türzer, Lien My Diep, Jan Oldenburg, Beata Gajdzik, Olesya Solheim, Erik Rud
KMSID: 1125145   J Gynecol Oncol. 2019;30(4):e56.  Published online 2019 February 27    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e56
         
e57 Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
Umberto Leone Roberti Maggiore, Fabio Martinelli, Giulia Dondi, Giorgio Bogani, Valentina Chiappa, Maria Teresa Evangelista, Viola Liberale, Antonino Ditto, Simone Ferrero, Francesco Raspagliesi
KMSID: 1125146   J Gynecol Oncol. 2019;30(4):e57.  Published online 2019 February 26    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e57
         
e58 Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus
Shirley Mei, Jennifer Gibbs, Katherine Economos, Yi-Chun Lee, Margaux J. Kanis
KMSID: 1125147   J Gynecol Oncol. 2019;30(4):e58.  Published online 2019 February 22    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e58
         
e59 Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
Marco Petrillo, Massimo Zucchetti, Stefano Cianci, Lavinia Morosi, Carlo Ronsini, Andrea Colombo, Maurizio D'Incalci, Giovanni Scambia, Anna Fagotti
KMSID: 1125148   J Gynecol Oncol. 2019;30(4):e59.  Published online 2019 March 1    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e59
         
e60 The influence of BRCA variants of unknown significance on cancer risk management decision-making
Jing-Yi Chern, Sarah S. Lee, Melissa K. Frey, Jessica Lee, Stephanie V. Blank
KMSID: 1125197   J Gynecol Oncol. 2019;30(4):e60.  Published online 2019 February 27    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e60
         
e61 A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer
Zhibo Zhang, Huifang Huang, Fengzhi Feng, Jinhui Wang, Ninghai Cheng
KMSID: 1125150   J Gynecol Oncol. 2019;30(4):e61.  Published online 2019 February 26    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e61
         
e62 Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study
Paolo Casadio, Francesca Guasina, Maria Rita Talamo, Roberto Paradisi, Ciro Morra, Giulia Magnarelli, Renato Seracchioli
KMSID: 1125151   J Gynecol Oncol. 2019;30(4):e62.  Published online 2019 April 22    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e62
         
e63 Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer
Isabel Ñiguez Sevilla, Francisco Machado Linde, Maria del Pilar Marín Sánchez, Julián Jesús Arense, Amparo Torroba, Anibal Nieto Díaz, Maria Luisa Sánchez Ferrer
KMSID: 1125152   J Gynecol Oncol. 2019;30(4):e63.  Published online 2019 March 4    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e63
         
e65 Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods
E Sun Paik, Jeong-Won Lee, Jeong-Yeol Park, Ju-Hyun Kim, Mijung Kim, Tae-Joong Kim, Chel Hun Choi, Byoung-Gie Kim, Duk-Soo Bae, Sung Wook Seo
KMSID: 1125153   J Gynecol Oncol. 2019;30(4):e65.  Published online 2019 March 11    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e65
         
e79 The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
Xiaojun Chen
KMSID: 1125154   J Gynecol Oncol. 2019;30(4):e79.  Published online 2019 April 1    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e79
         
e80 Clinical significance of variants of unknown significances in BRCA genes
Min Chul Choi
KMSID: 1125155   J Gynecol Oncol. 2019;30(4):e80.  Published online 2019 May 9    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e80
         
e82 A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial
Siriwan Tangjitgamol, Ekkasit Tharavichitkul, Chokaew Tovanabutra, Kanisa Rongsriyam, Tussawan Asakij, Kannika Paengchit, Jirasak Sukhaboon, Somkit Penpattanagul, Apiradee Kridakara, Jitti Hanprasertpong, Kittisak Chomprasert, Sirentra Wanglikitkoon, Thiti Atjimakul, Piyawan Pariyawateekul, Kanyarat Katanyoo, Prapai Tanprasert, Wanwipa Janweerachai, Duangjai Sangthawan, Jakkapan Khunnarong, Taywin Chottetanaprasith, Busaba Supawattanabodee, Prasert Lertsanguansinchai, Jatupol Srisomboon, Wanrudee Isaranuwatchai, Vichan Lorvidhaya
KMSID: 1125156   J Gynecol Oncol. 2019;30(4):e82.  Published online 2019 April 10    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e82
         
e87 Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia
Eduardo Paulino, Andreia Cristina de Melo
KMSID: 1125157   J Gynecol Oncol. 2019;30(4):e87.  Published online 2019 April 22    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e87
         
e91 The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report
Ga Won Yim, Dong Hoon Suh, Jae-Weon Kim, Seung Cheol Kim, Young Tae Kim
KMSID: 1125158   J Gynecol Oncol. 2019;30(4):e91.  Published online 2019 May 17    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e91
         
e97 Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken
Sudeep Gupta
KMSID: 1125196   J Gynecol Oncol. 2019;30(4):e97.  Published online 2019 May 22    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e97
         
e51 Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database
Hyun-Woong Cho, Yung-Taek Ouh, Jae Kwan Lee, Jin Hwa Hong
KMSID: 1148322   J Gynecol Oncol. 2019;30(4):e51.  Published online 2019 January 25    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e51
         
e54 Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes
Hanifi Şahin, Funda Karatas, Gonca Coban, Özlem Özen, Özlem Erdem, Mehmet Anıl Onan, Ali Ayhan
KMSID: 1148323   J Gynecol Oncol. 2019;30(4):e54.  Published online 2019 February 4    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e54
         
Articles from Journal of Gynecologic Oncology are provided here courtesy of Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology